NEDOCROMIL SODIUM - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for nedocromil sodium and what is the scope of patent protection?

Nedocromil sodium is the generic ingredient in three branded drugs marketed by King Pharms Llc, Allergan, Epic Pharma Llc, and Sanofi Aventis Us, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nedocromil sodium. One supplier is listed for this compound.

Summary for NEDOCROMIL SODIUM

US Patents:	0
Tradenames:	3
Applicants:	4
NDAs:	4
Drug Master File Entries:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	43
Clinical Trials:	7
Patent Applications:	5,834
What excipients (inactive ingredients) are in NEDOCROMIL SODIUM?	NEDOCROMIL SODIUM excipients list
DailyMed Link:	NEDOCROMIL SODIUM at DailyMed

Recent Clinical Trials for NEDOCROMIL SODIUM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Indiana University	Phase 4
Childhood Asthma Research and Education Network	Phase 3
Imperial College London	Phase 2

See all NEDOCROMIL SODIUM clinical trials

Pharmacology for NEDOCROMIL SODIUM

Drug Class	Mast Cell Stabilizer
Physiological Effect	Decreased Histamine Release

Medical Subject Heading (MeSH) Categories for NEDOCROMIL SODIUM

Anti-Allergic Agents
Anti-Asthmatic Agents
Anti-Inflammatory Agents

Anatomical Therapeutic Chemical (ATC) Classes for NEDOCROMIL SODIUM

US Patents and Regulatory Information for NEDOCROMIL SODIUM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Allergan	ALOCRIL	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	021009-001	Dec 8, 1999		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Epic Pharma Llc	NEDOCROMIL SODIUM	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	090638-001	Aug 22, 2012		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
King Pharms Llc	TILADE	nedocromil sodium	AEROSOL, METERED;INHALATION	019660-001	Dec 30, 1992		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sanofi Aventis Us	TILADE	nedocromil sodium	SOLUTION;INHALATION	020750-001	Oct 1, 1997		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for NEDOCROMIL SODIUM

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Allergan	ALOCRIL	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	021009-001	Dec 8, 1999	⤷ Sign Up	⤷ Sign Up
King Pharms Llc	TILADE	nedocromil sodium	AEROSOL, METERED;INHALATION	019660-001	Dec 30, 1992	⤷ Sign Up	⤷ Sign Up
Allergan	ALOCRIL	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	021009-001	Dec 8, 1999	⤷ Sign Up	⤷ Sign Up
King Pharms Llc	TILADE	nedocromil sodium	AEROSOL, METERED;INHALATION	019660-001	Dec 30, 1992	⤷ Sign Up	⤷ Sign Up
Allergan	ALOCRIL	nedocromil sodium	SOLUTION/DROPS;OPHTHALMIC	021009-001	Dec 8, 1999	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.